← FDA DRUG APPROVALS

FDA ANDA · ANDA074097

ISOFLURANE

Sponsor: HOSPIRA

APPLICATION
ANDA074097
TYPE
ANDA
ORIGINAL APPROVAL
1993-01-25
LATEST ACTION
2007-09-25
ROUTE
INHALATION
DOSAGE FORM
LIQUID
MARKETING STATUS
Discontinued

Products

ISOFLURANEDiscontinued
ISOFLURANE 99.9% · LIQUID · INHALATION

Approval history

2007-09-25Labeling · Supplement 9AP
2000-05-15Labeling · Supplement 8AP
1996-08-16Labeling · Supplement 7AP
1995-07-06Manufacturing (CMC) · Supplement 4AP
1995-07-06Labeling · Supplement 2AP
1995-07-06Manufacturing (CMC) · Supplement 5AP
1995-07-06Manufacturing (CMC) · Supplement 3AP
1995-07-06Manufacturing (CMC) · Supplement 1AP
1993-01-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →